» Articles » PMID: 34439777

Analyzing Modern Biomolecules: The Revolution of Nucleic-Acid Sequencing - Review

Overview
Journal Biomolecules
Publisher MDPI
Date 2021 Aug 27
PMID 34439777
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Recent developments have revolutionized the study of biomolecules. Among them are molecular markers, amplification and sequencing of nucleic acids. The latter is classified into three generations. The first allows to sequence small DNA fragments. The second one increases throughput, reducing turnaround and pricing, and is therefore more convenient to sequence full genomes and transcriptomes. The third generation is currently pushing technology to its limits, being able to sequence single molecules, without previous amplification, which was previously impossible. Besides, this represents a new revolution, allowing researchers to directly sequence RNA without previous retrotranscription. These technologies are having a significant impact on different areas, such as medicine, agronomy, ecology and biotechnology. Additionally, the study of biomolecules is revealing interesting evolutionary information. That includes deciphering what makes us human, including phenomena like non-coding RNA expansion. All this is redefining the concept of gene and transcript. Basic analyses and applications are now facilitated with new genome editing tools, such as CRISPR. All these developments, in general, and nucleic-acid sequencing, in particular, are opening a new exciting era of biomolecule analyses and applications, including personalized medicine, and diagnosis and prevention of diseases for humans and other animals.

Citing Articles

The Research Progress of Single-Molecule Sequencing and Its Significance in Nucleic Acid Metrology.

Wang Y, Liu J, Wang Z, Zhang M, Zhang Y Biosensors (Basel). 2025; 15(1).

PMID: 39852055 PMC: 11763189. DOI: 10.3390/bios15010004.


Integrative analysis of autophagy-related genes reveals that CAPNS1 is a novel prognostic biomarker and promotes the malignancy of melanoma via Notch signaling pathway.

Gao M, Liu J, Yang M, Zhang X, Zhang Y, Zhou Z Am J Cancer Res. 2024; 14(8):3665-3693.

PMID: 39267668 PMC: 11387868. DOI: 10.62347/ECDF2762.


circRNAs as Epigenetic Regulators of Integrity in Blood-Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis.

DAversa E, Salvatori F, Vaccarezza M, Antonica B, Grisafi M, Singh A Cells. 2024; 13(16.

PMID: 39195206 PMC: 11352526. DOI: 10.3390/cells13161316.


Identification of crosstalk genes and immune characteristics between Alzheimer's disease and atherosclerosis.

An W, Zhou J, Qiu Z, Wang P, Han X, Cheng Y Front Immunol. 2024; 15:1443464.

PMID: 39188714 PMC: 11345154. DOI: 10.3389/fimmu.2024.1443464.


Isovaleryl Sucrose Esters from and Their Cytotoxic Activity.

Wang Y, Wang Z, Sun Y, Zhu M, Jiang Y, Bai H Molecules. 2024; 29(13).

PMID: 38999021 PMC: 11243297. DOI: 10.3390/molecules29133069.


References
1.
Pan Y, Kadash-Edmondson K, Wang R, Phillips J, Liu S, Ribas A . RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets. Trends Pharmacol Sci. 2021; 42(4):268-282. PMC: 8761020. DOI: 10.1016/j.tips.2021.01.006. View

2.
Cusco A, Perez D, Vines J, Fabregas N, Francino O . Long-read metagenomics retrieves complete single-contig bacterial genomes from canine feces. BMC Genomics. 2021; 22(1):330. PMC: 8103633. DOI: 10.1186/s12864-021-07607-0. View

3.
Guruprasad P, Lee Y, Kim K, Ruella M . The current landscape of single-cell transcriptomics for cancer immunotherapy. J Exp Med. 2021; 218(1). PMC: 7754680. DOI: 10.1084/jem.20201574. View

4.
Schultzhaus Z, Wang Z, Stenger D . CRISPR-based enrichment strategies for targeted sequencing. Biotechnol Adv. 2020; 46:107672. DOI: 10.1016/j.biotechadv.2020.107672. View

5.
Poole O, Pizzamiglio C, Murphy D, Falabella M, Macken W, Bugiardini E . Mitochondrial DNA Analysis from Exome Sequencing Data Improves Diagnostic Yield in Neurological Diseases. Ann Neurol. 2021; 89(6):1240-1247. PMC: 8494076. DOI: 10.1002/ana.26063. View